Literature DB >> 16192628

C-reactive protein and atherogenesis: new insights from established animal models.

Jan Torzewski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16192628      PMCID： PMC1603681          DOI： 10.1016/S0002-9440(10)61182-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  35 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Generation of C-reactive protein and complement components in atherosclerotic plaques.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Authors:  T P Zwaka; V Hombach; J Torzewski
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

4.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Direct proinflammatory effect of C-reactive protein on human endothelial cells.

Authors:  V Pasceri; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

6.  C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis.

Authors:  M Torzewski; C Rist; R F Mortensen; T P Zwaka; M Bienek; J Waltenberger; W Koenig; G Schmitz; V Hombach; J Torzewski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

7.  C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.

Authors:  Chao-Hung Wang; Shu-Hong Li; Richard D Weisel; Paul W M Fedak; Aaron S Dumont; Paul Szmitko; Ren-Ke Li; Donald A G Mickle; Subodh Verma
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

8.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.

Authors:  F C de Beer; A K Soutar; M L Baltz; I M Trayner; A Feinstein; M B Pepys
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307
View more
  11 in total

Review 1.  What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease?

Authors:  Benjamin J W Chow; John P Veinot
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

2.  Affinity of C-reactive protein toward FcgammaRI is strongly enhanced by the gamma-chain.

Authors:  Carlheinz Röcker; Dimitar E Manolov; Elza V Kuzmenkina; Kyrylo Tron; Holger Slatosch; Jan Torzewski; G Ulrich Nienhaus
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome.

Authors:  Michal Pravenec; Takashi Kajiya; Václav Zídek; Vladimír Landa; Petr Mlejnek; Miroslava Simáková; Jan Silhavý; Hana Malínská; Olena Oliyarnyk; Ludmila Kazdová; Jianglin Fan; Jiaming Wang; Theodore W Kurtz
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

4.  M1 Macrophages but Not M2 Macrophages Are Characterized by Upregulation of CRP Expression via Activation of NFκB: a Possible Role for Ox-LDL in Macrophage Polarization.

Authors:  Marielle Kaplan; Anna Shur; Yvgeny Tendler
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

5.  Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats.

Authors:  Mengliu Yang; Sheng Qiu; Yirui He; Ling Li; Tong Wu; Ning Ding; Fanghong Li; Allan Z Zhao; Gangyi Yang
Journal:  Diabetologia       Date:  2021-02-05       Impact factor: 10.122

Review 6.  C-reactive protein in human atherogenesis: facts and fiction.

Authors:  Oliver Zimmermann; Kefei Li; Myron Zaczkiewicz; Matthias Graf; Zhongmin Liu; Jan Torzewski
Journal:  Mediators Inflamm       Date:  2014-04-01       Impact factor: 4.711

7.  Interleukin 2 Topical Cream for Treatment of Diabetic Foot Ulcer: Experiment Protocol.

Authors:  Shu Wing Sophia Chan
Journal:  JMIR Res Protoc       Date:  2015-08-14

Review 8.  Thrombus Formation and Propagation in the Onset of Cardiovascular Events.

Authors:  Yujiro Asada; Atsushi Yamashita; Yuichiro Sato; Kinta Hatakeyama
Journal:  J Atheroscler Thromb       Date:  2018-06-09       Impact factor: 4.928

9.  C-Reactive Protein (CRP) Blocks the Desensitization of Agonistic Stimulated G Protein Coupled Receptors (GPCRs) in Neonatal Rat Cardiomyocytes.

Authors:  Gerd Wallukat; Stephan Mattecka; Katrin Wenzel; Wieland Schrödl; Birgit Vogt; Patrizia Brunner; Ahmed Sheriff; Rudolf Kunze
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

Review 10.  Animal models of C-reactive protein.

Authors:  Michael Torzewski; Ahmed Bilal Waqar; Jianglin Fan
Journal:  Mediators Inflamm       Date:  2014-04-24       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.